Author Archives: Clark Herman

Kineta: Creative Financing Bridges the "Valley of Death"

At a time when burst bubbles have created uncertainty for investors in the biomedical realm, it’s smart for a drug company to make use of new legislation and emerging trends in venture capital. This is particularly true in spurring confidence in that translational area of drug development many deem the “Valley of Death”. PharmExec caught […]
Posted in Biotech, Deals, leadership, R&D, Regulatory, Strategy | Tagged , , , , , , , , , , , , , , , | Leave a comment

New Tool to Adherence: Oncology Nursing

With Adherence becoming a rallying cry for industry, new technologies are being tested to get patients to take their medicines, with much of the momentum focused on smartphone and tablet-specific approaches. Yesterday, ONS:Edge, a medical communications company unveiled a new partnership with the Mobile Health Library™ (MHL), a mobile-focused clinical engagement platform to provide apps […]
Posted in E-Media, healthcare, multimedia, Patient Communication, patient compliance, patient education | Tagged , , , , , , | Leave a comment

Drug Reimbursement: Make Room at the Table for Patients and Researchers

At last week’s Partnering for Cures conference held in New York City, several expert panels discussed new angles of approaching solutions to disease, encouraging investment and mitigating inefficiencies in the delivery of medicines within the current healthcare system. A highlight was a session on  “Reimbursement: Can Value Drive Innovation?,” which looked at  defining value in […]
Posted in Events, FDA, healthcare, Market Access, pricing | Tagged , , , , , , , , , , , , , , , , | Leave a comment

CEOs Sound Out on Health Reform: Stop Swinging from the Fence

At last week’s  4th annual Prix Galien Forum hosted by the Alexandria Center in New York, industry leaders gathered to discuss trends and developments that shape the intersection between science and policy.  The centerpiece of the day was a panel on  US health reform – focused on rollout of the  Affordable Care Act — featuring […]
Posted in Events, leadership, People, R&D, Regulatory | Tagged , , , , , , , , , , , , | Leave a comment

Does IP Stimulate Growth and Create Jobs? New European Data Says Yes

A new study shows the importance of intellectual property in stimulating jobs and productivity in the EU. Surprisingly, it illustrates pharma’s established position as an IP powerhouse, evidence that adds conviction to the views expressed by GSK CEO Andrew Witty and other industry leaders that growing cuts on drug pricing are limiting an industry that […]
Posted in Europe, IP | Tagged , , , , , , , , | Leave a comment
  • Categories

  • Meta